Nearly one month out from the end of the public health emergency in the U.S., hospitalizations are on the rise in 16 different states, and a new omicron subvariant has been spotted in 18 states.
Gov. Gavin Newsom declared that California would cut ties with Walgreens after the company said it would not distribute abortion pills in some states. But federal rules make it difficult for the state to unwind its Medicaid prescription drug agreement, which paid Walgreens $1.5 billion last year.
While some aspects of long COVID-19 — sometimes referred to as post-COVID-19 condition, or PCC — are much better understood than before, researchers have yet to land on a unified definition for the condition.
Overall, flu activity in the U.S. remains low and is down significantly from the late fall peak. However, the percentage of specimens testing positive for influenza B has risen in recent weeks.
Researchers and international organizations are probing for more information on long COVID studies run by the National Institutes of Health because of exercise measurements, Nature reported March 31.
Widespread mixtures of fentanyl and xylazine are causing concern for health officials in South Dakota — particularly because the combination cannot be aided by naloxone, according to an April 4 news release from the state’s department of health.
The federal government plans to build a massive Alzheimer’s research database capable of tracking the long-term health of up to 90 percent of the population, according to an exclusive April 3 report from Reuters.
Candida auris infections are increasingly on the rise across the U.S. — something the CDC has cited as “an emerging fungus that presents a serious global health threat.” Now, the fungus has induced infections across dozens of states.